{"id":452294,"date":"2021-03-08T06:34:12","date_gmt":"2021-03-08T11:34:12","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=452294"},"modified":"2021-03-08T06:34:12","modified_gmt":"2021-03-08T11:34:12","slug":"chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/","title":{"rendered":"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board"},"content":{"rendered":"

<\/p>\n

ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board<\/b><\/p>\n

Globally recognized authority on lifestyle medicine joins ChromaDex SAB to bolster company\u2019s healthy aging research efforts <\/i><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–
\nChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. Katz, MD, MPH, FACPM, FACP, FACLM – CEO of Diet ID, Inc, founder and former director of Yale University\u2019s Yale-Griffin Prevention Research Center and past president of the American College of Lifestyle Medicine, to its Scientific Advisory Board (SAB). Dr. Katz is a leading expert in nutrition, health promotion and the prevention of chronic disease through his work as a researcher, author and clinician.\n<\/p>\n

\nAs CEO of Diet ID, Dr. Katz oversees a team working to make diet a vital sign, leveraging an advance in dietary assessment. He also serves as president for True Health Initiative<\/a>, a non-profit organization that he established to defend and disseminate the science, sense, and global expert consensus about healthy, sustainable diet and lifestyle in the service of \u201cadding years to lives and life to years around the globe.\u201d\n<\/p>\n

\nDr. Katz earned his B.A. degree from Dartmouth College, his M.D. from the Albert Einstein College of Medicine and his M.P.H. from the Yale University School of Public Health. Katz completed sequential residency training in Internal Medicine and Preventive Medicine\/Public Health, earning board certification in both disciplines. He provided care to patients in an academic practice model for nearly 30 years.\n<\/p>\n

\n\u201cWe are honored that Dr. Katz has agreed to join our distinguished board of scientific advisors,\u201d said ChromaDex CEO Rob Fried. \u201cHis background as a world renowned clinician and researcher complements those of the existing members in our mission to understand the many ways NAD+<\/sup> and NR can improve human health.\u201d\n<\/p>\n

\n\u201cIt is a privilege to join the ChromaDex Scientific Advisory Board, a company that has made formidable strides toward improving healthspans,\u201d said Dr. Katz. \u201cI look forward to working with world-leading scientists to deepen our knowledge on how NAD+<\/sup> and lifestyle interventions can support the aging population.\u201d\n<\/p>\n

\nDr. Katz is credited with inventing multiple research methods and clinical trial approaches for preventive medicine. Notably, he developed \u201cevidence mapping,\u201d a research method that describes the level of research done in a broad topic of medicine and how that research is distributed. Evidence mapping has since been adopted by the World Health Organization. He also created a clinical trial approach called the multi-site translational community trial (MTCT), which bridges the gap between what a clinical trial theoretically demonstrates can work versus what is needed to make it effective in real-world settings. Most recently, he designed \u201cevidence threshold pathway mapping,\u201d a method dedicated to understanding lifetime effects of health behaviors.\n<\/p>\n

\nRecognized by peers as the \u201cpoet laureate of health promotion,\u201d Dr. Katz has delivered talks in all 50 states and in countries on six continents. He has served as an on-air medical contributor for Good Morning America\/ABC News<\/i>, has been recognized with three honorary doctorate degrees, and was a finalist for a James Beard Foundation Award in 2019 for health journalism pieces in New York<\/i> magazine. He has published 18 books and more than 200 scientific articles and textbook chapters.\n<\/p>\n

\nFor additional information about ChromaDex, please visit www.chromadex.com<\/a>.\n<\/p>\n

About ChromaDex:<\/b><\/p>\n

\nChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen\u00ae. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex\u2019s patent portfolio. ChromaDex delivers Niagen\u00ae as the sole active ingredient in its consumer product Tru Niagen\u00ae available at www.truniagen.com<\/a> and through partnerships with global retailers and distributors. ChromaDex maintains a website at www.chromadex.com<\/a> to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.\n<\/p>\n

Forward-Looking Statements:<\/b><\/p>\n

\nThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as “expects,” “anticipates,” “intends,” “estimates,” “plans,” “potential,” “possible,” “probable,” “believes,” “seeks,” “may,” “will,” “should,” “could” or the negative of such terms or other similar expressions. More detailed information about ChromaDex and the risk factors that may affect the realization of forward-looking statements is set forth in ChromaDex’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 as amended, ChromaDex’s Quarterly Reports on Form 10-Q and other filings submitted by ChromaDex to the SEC, copies of which may be obtained from the SEC’s website at www.sec.gov<\/a>. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement and ChromaDex undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210308005123\/en\/<\/a><\/span><\/p>\n

ChromaDex Media Contact:
\n<\/b>
Alex Worsham, Vice President of Global Marketing & Communications
\n
310-388-6706 ext. 689
\n
alexw@chromadex.com<\/a><\/p>\n

ChromaDex Investor Relations Contact:
\n<\/b>
Brianna Gerber, Vice President of FP&A and Investor Relations
\n
949-419-0288 ext. 127
\n
briannag@chromadex.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Alternative Medicine Health General Health Seniors Other Science Research Fitness & Nutrition Consumer Science Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board Globally recognized authority on lifestyle medicine joins ChromaDex SAB to bolster company\u2019s healthy aging research efforts LOS ANGELES–(BUSINESS WIRE)– ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. Katz, MD, MPH, FACPM, FACP, FACLM – CEO of Diet ID, Inc, founder and former director of Yale University\u2019s Yale-Griffin Prevention Research Center and past president of the American College of Lifestyle Medicine, to its Scientific Advisory Board (SAB). Dr. Katz is a leading expert in nutrition, health promotion and the prevention of chronic disease through his work as a researcher, author and clinician. As CEO of Diet ID, Dr. Katz oversees a team working to make … <\/p>\n

Continue reading “ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-452294","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board Globally recognized authority on lifestyle medicine joins ChromaDex SAB to bolster company\u2019s healthy aging research efforts LOS ANGELES–(BUSINESS WIRE)– ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. Katz, MD, MPH, FACPM, FACP, FACLM – CEO of Diet ID, Inc, founder and former director of Yale University\u2019s Yale-Griffin Prevention Research Center and past president of the American College of Lifestyle Medicine, to its Scientific Advisory Board (SAB). Dr. Katz is a leading expert in nutrition, health promotion and the prevention of chronic disease through his work as a researcher, author and clinician. As CEO of Diet ID, Dr. Katz oversees a team working to make … Continue reading "ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-08T11:34:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board\",\"datePublished\":\"2021-03-08T11:34:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/\"},\"wordCount\":965,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/\",\"name\":\"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-03-08T11:34:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Market Newsdesk","og_description":"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board Globally recognized authority on lifestyle medicine joins ChromaDex SAB to bolster company\u2019s healthy aging research efforts LOS ANGELES–(BUSINESS WIRE)– ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. Katz, MD, MPH, FACPM, FACP, FACLM – CEO of Diet ID, Inc, founder and former director of Yale University\u2019s Yale-Griffin Prevention Research Center and past president of the American College of Lifestyle Medicine, to its Scientific Advisory Board (SAB). Dr. Katz is a leading expert in nutrition, health promotion and the prevention of chronic disease through his work as a researcher, author and clinician. As CEO of Diet ID, Dr. Katz oversees a team working to make … Continue reading \"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-08T11:34:12+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board","datePublished":"2021-03-08T11:34:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/"},"wordCount":965,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/","name":"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-03-08T11:34:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210308005123r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chromadex-appoints-preventative-medicine-specialist-dr-david-l-katz-to-its-scientific-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=452294"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452294\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=452294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=452294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=452294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}